Invest Now in Encompass Health Stock for Long-Term Gains!

January 2, 2024

☀️Trending News

Now is an ideal time to consider investing in Encompass Health ($NYSE:EHC) stock for long-term gains. Their focus on providing coordinated, patient-centered care across the healthcare continuum enables them to provide seamless transitions of care that result in better patient outcomes. They are also dedicated to helping people with disabilities and chronic illnesses get back to a higher quality of life through rehabilitation, home health and hospice services. Encompass Health offers investors the potential for long-term capital appreciation as well as potential dividend payments. The company’s strong balance sheet and experienced management team provide a solid foundation for growth. They also have a comprehensive portfolio of innovative products and services designed to meet the needs of their customers. With a wide variety of offerings, Encompass Health is well-positioned to benefit from the growing demand for post-acute care in the US healthcare market. The company has a history of strong performance and has grown its earnings at an impressive rate for the last few years.

In addition, they offer a generous dividend yield, making them an attractive choice for income-seeking investors. With their commitment to providing quality patient care and strong financials, Encompass Health is well-positioned for continued success. Investing in this company now could provide investors with the potential for significant returns in the years ahead.

Market Price

Now is the perfect time to invest in ENCOMPASS HEALTH, one of the leading healthcare providers in the United States. On Thursday, the stock opened at $67.3 and closed at $67.2, down by 0.5% from last closing price of 67.6. This slight decrease in price provides an excellent opportunity to buy in and make long-term gains. Given ENCOMPASS HEALTH’s strong track record of success and continued growth, investing in its stock today could pay off handsomely in the future. The company has a well-established management team which has delivered consistent results over the years.

Furthermore, with the current healthcare landscape, ENCOMPASS HEALTH’s services are more sought after than ever before. All of these factors make it a great time to invest in ENCOMPASS HEALTH stock. The current decrease in price provides a great entry point for investors to get in on the action and reap long-term rewards. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Encompass Health. More…

    Total Revenues Net Income Net Margin
    4.69k 352.6 7.6%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Encompass Health. More…

    Operations Investing Financing
    822 -601.1 -183.8
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Encompass Health. More…

    Total Assets Total Liabilities Book Value Per Share
    5.96k 3.78k 15.57
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Encompass Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    0.6% 5.3% 15.8%
    FCF Margin ROE ROA
    5.4% 30.4% 7.7%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale conducted an in-depth analysis of ENCOMPASS HEALTH‘s wellness. The results of our Star Chart analysis revealed that ENCOMPASS HEALTH has a high health score of 8/10, indicating that it is in a strong financial position and capable of sustaining future operations even in times of crisis. We also found that ENCOMPASS HEALTH is relatively strong in terms of dividends and profitability, but relatively weak in terms of assets and growth. Based on these results, we concluded that ENCOMPASS HEALTH is a ‘cow’, a type of company that has the track record of paying out consistent and sustainable dividends. Given its sound financial position and its ability to pay out consistent dividends, investors who are looking for a steady income stream with low risk may be interested in ENCOMPASS HEALTH. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    There is fierce competition between Encompass Health Corp and its competitors: Community Health Systems Inc, Pennant Group Inc, Greenbrook TMS Inc. All four companies are leaders in the healthcare industry and are constantly striving to be the best.

    – Community Health Systems Inc ($NYSE:CYH)

    The company’s market capitalization is 311.19 million as of 2022. The company’s return on equity is -48.01%. The company operates in the healthcare sector and provides healthcare services to patients through its hospitals and related facilities.

    – Pennant Group Inc ($NASDAQ:PNTG)

    Pennant Group, Inc. provides healthcare services in the United States. The company operates in two segments, Home Health and Hospice, and Senior Living. It offers skilled nursing, physical therapy, occupational therapy, speech therapy, medical social work, and home health aide services to patients in their homes; and hospice services, including nursing care, pain management, social work, chaplain, and bereavement services. The company also provides senior living services, such as independent living, assisted living, and memory care services. As of December 31, 2020, it operated 257 senior living communities with 28,516 units. The company was formerly known as Curo Health Services, Inc. and changed its name to Pennant Group, Inc. in July 2018. Pennant Group, Inc. was founded in 2006 and is headquartered in Carrollton, Texas.

    – Greenbrook TMS Inc ($TSX:GTMS)

    Greenbrook TMS Inc is a healthcare company that provides treatment for depression and other mental disorders. The company has a market capitalization of 123.09M and a return on equity of -213.16%. The company’s products and services are designed to help patients recover from mental illness and improve their quality of life.

    Summary

    Encompass Health Corporation offers healthcare services in the United States and is well-positioned to benefit from the current healthcare environment and advances in technology. The company’s stock has been performing well in recent months, and analysts expect its stock to remain strong. Encompass Health’s balance sheet is very healthy with a strong cash position, low debt, and a solid margin profile. It boasts a well-diversified revenue stream with a broad range of services, from post-acute care and home health services to telehealth and innovative technology.

    Additionally, the company’s strategic acquisitions have also helped to diversify its portfolio and enhance earnings growth. With a growing customer base, solid market share, and good growth prospects, Encompass Health is a great option for investors looking for long-term opportunities.

    Recent Posts

    Leave a Comment